These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 33376572)

  • 1. Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study.
    Florido-López JF; Andreu-Balaguer C; Escudero C; Seoane-Rodríguez M; Hernández M; Navarro-Seisdedos LÁ; Torrecillas-Toro M; Anton-Girones M; Herrero-Lifona L; Brugaletta D; Macías J; Pineda R; Lara MÁ; López-Caballero J; Rojas MJ
    World Allergy Organ J; 2020 Dec; 13(12):100487. PubMed ID: 33376572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
    Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
    Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Safety and Effectiveness Evidence of a Microcrystalline Tyrosine-Associated Mite Allergoid in Children and Adolescents with Allergic Rhinitis.
    Anna SC; Zulay M AS; Ignacio GN; Sofia L; Juan A MT; Maria D M; Ramón N; Mercedes R; Anna B; Carla TB; José L J
    Allergol Immunopathol (Madr); 2021; 49(4):98-108. PubMed ID: 34224224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness of a microcrystalline tyrosine-associated mite extract immunotherapy for allergic rhinitis.
    Sala-Cunill A; Pérez-Formoso JL; Torán-Barona C; Almeida-Sánchez ZM; Álvarez-Fernández JA; García-Núñez I; Linana-Santafé JJ; Martínez-Tadeo JA; Boronat-Barado A; Justicia JL
    Immunotherapy; 2020 Sep; 12(13):1007-1019. PubMed ID: 32811270
    [No Abstract]   [Full Text] [Related]  

  • 5. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.
    Larenas-Linnemann D; Rodríguez-Pérez N; Luna-Pech JA; Rodríguez-González M; Blandón-Vijil MV; Del-Río-Navarro BE; Costa-Domínguez MDC; Navarrete-Rodríguez EM; Macouzet-Sánchez C; Ortega-Martell JA; Pozo-Beltrán CF; Estrada-Cardona A; Arias-Cruz A; Rodríguez Galván KG; Brito-Díaz H; Canseco-Raymundo MDR; Castelán-Chávez EE; Escalante-Domínguez AJ; Gálvez-Romero JL; Gómez-Vera J; González-Díaz SN; Guerrero-Núñez MGB; Hernández-Colín DD; Macías-Weinmann A; Mendoza-Hernández DA; Meneses-Sánchez NA; Mogica-Martínez MD; Moncayo-Coello CV; Montiel-Herrera JM; O'Farril-Romanillos PM; Onuma-Takane E; Ortega-Cisneros M; Rangel-Garza L; Stone-Aguilar H; Torres-Lozano C; Venegas-Montoya E; Wakida-Kusunoki G; Partida-Gaytán A; López-García AI; Macías-Robles AP; Ambriz-Moreno MJ; Azamar-Jácome AA; Beltrán-De Paz CY; Caballero-López C; Fernández de Córdova-Aguirre JC; Fernández-Soto JR; Lozano-Sáenz JS; Oyoqui-Flores JJ; Osorio-Escamilla RE; Ramírez-Jiménez F; Rivero-Yeverino D; Martínez Infante E; Medina-Ávalos MA
    World Allergy Organ J; 2020 Aug; 13(8):100444. PubMed ID: 32884611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma.
    Vogelberg C; Brüggenjürgen B; Richter H; Jutel M
    Patient Prefer Adherence; 2020; 14():817-827. PubMed ID: 32494127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of pollen allergoid tyrosine-adsorbed subcutaneous immunotherapy on allergic rhinitis and asthma.
    Vogelberg C; Klimek L; Kruppert S; Becker S
    Clin Exp Allergy; 2024 Apr; 54(4):253-264. PubMed ID: 38146840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-short-course booster is effective in recurrent grass pollen-induced allergic rhinoconjunctivitis.
    Pfaar O; Lang S; Pieper-Fürst U; Astvatsatourov A; Gerich F; Klimek L; Kramer MF; Reydelet Y; Shah-Hosseini K; Mösges R
    Allergy; 2018 Jan; 73(1):187-195. PubMed ID: 28675499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies.
    Rosewich M; Girod K; Zielen S; Schubert R; Schulze J
    Allergy Asthma Immunol Res; 2016 May; 8(3):257-63. PubMed ID: 26922936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma.
    Wahn U; Bachert C; Heinrich J; Richter H; Zielen S
    Allergy; 2019 Mar; 74(3):594-604. PubMed ID: 30183091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and adverse reactions to subcutaneous immunotherapy in children with allergic rhinitis/asthma.
    Duman Senol H; Topyildiz E; Ekici B; Gulen F; Demir E
    Int J Pediatr Otorhinolaryngol; 2022 Nov; 162():111292. PubMed ID: 36007303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-short-course seasonal allergy vaccine (Pollinex Quattro).
    McCormack PL; Wagstaff AJ
    Drugs; 2006; 66(7):931-8. PubMed ID: 16740007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis.
    Rosewich M; Lee D; Zielen S
    Hum Vaccin Immunother; 2013 Jul; 9(7):1523-31. PubMed ID: 23584250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational study.
    Padró C; Gutiérrez D; Moreno F; Parra A; Rial MJ; Lleonart R; Torán-Barona C; Justicia JL; Roger A
    Immun Inflamm Dis; 2022 May; 10(5):e585. PubMed ID: 35478444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy.
    Starchenka S; Heath MD; Lineberry A; Higenbottam T; Skinner MA
    World Allergy Organ J; 2019 Nov; 12(11):100087. PubMed ID: 31768216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of monophosphoryl lipid A adjuvanted specific immunotherapy in patients with grass pollen allergy.
    Zielen S; Gabrielpillai J; Herrmann E; Schulze J; Schubert R; Rosewich M
    Immunotherapy; 2018 Jun; 10(7):529-536. PubMed ID: 29562801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing.
    Zielen S; Kuna P; Aberer W; Lassmann S; Pfaar O; Klimek L; Wade A; Kluehr K; Raab J; Wessiepe D; Lee D; Kramer MF; Gunawardena K; Higenbottam T; Heath MD; Skinner MA; de Kam PJ
    World Allergy Organ J; 2019 Nov; 12(11):100075. PubMed ID: 31709029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in patients with respiratory allergy is influenced by the causative allergen.
    Delgado J; Dávila ID; Domínguez-Ortega J; Quirce S; Martí-Guadaño E; Valero A
    J Investig Allergol Clin Immunol; 2013; 23(5):309-14. PubMed ID: 24260975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy.
    Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
    Otolaryngol Head Neck Surg; 2024 Mar; 170(3):635-667. PubMed ID: 38408153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.